Earnings Outlook For Kura Oncology
Portfolio Pulse from Benzinga Insights
Kura Oncology (NASDAQ:KURA) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-0.55. The company's past performance shows a trend of beating EPS estimates, leading to positive stock price movements. Shares are currently trading at $20.25, reflecting a 73.15% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's future guidance.
February 26, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Kura Oncology is expected to report an EPS of $-0.55 for the upcoming quarter. Historical data shows positive stock movement following earnings beats. Shares have seen a significant increase over the past year.
Given Kura Oncology's history of exceeding EPS estimates and the subsequent positive impact on its stock price, there is a strong likelihood of a positive short-term price movement if the company beats the EPS estimate again. The anticipation of future guidance also plays a crucial role in investor sentiment.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100